The CEO of SaNOtize is tapping into outside-the-box innovation to develop a nitric oxide-delivery platform to treat and prevent COVID-19.
Read more here.
The CEO of SaNOtize is tapping into outside-the-box innovation to develop a nitric oxide-delivery platform to treat and prevent COVID-19.
Read more here.
![[OurCrowd in The Wall Street Journal] OurCrowd aims to raise $200 million WHO-affiliated Global Health Fund](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
